Lv11
38 积分 2024-02-26 加入
A Multicenter, Real-World Comparative Cohort Study of Neoadjuvant EGFR-TKI Therapy with or without Chemotherapy in Resectable EGFR-Mutant NSCLC
11小时前
求助中
Tumor inflammation-associated neurotoxicity
2个月前
已完结
NSCLC: Five trials to watch
3个月前
已完结
Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer
3个月前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
4个月前
已完结
Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration
4个月前
已完结
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
8个月前
已完结
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
8个月前
已完结
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non–Small Cell Lung Cancer
11个月前
已完结
Adjuvant Immunotherapy Does Not Improve Survival in Non-small Cell Lung Cancer with Major/Complete Pathological Response after Induction Immunotherapy
1年前
已完结
皖公网安备34019202002308
